Focus Financial Partners (NASDAQ:FOCS) reported quarterly earnings of $0.99 per share which beat the analyst consensus estimate of $0.91 by 8.79 percent. This is a 5.32 percent increase over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $547.68 million which beat the analyst consensus estimate of $516.79 million by 5.98 percent. This is a 4.54 percent increase over sales of $523.89 million the same period last year.
Vir Biotech Reports First Marketing Authorization For Its First Commercial Product, Sotrovimab, Granted In Australia
Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the first marketing authorization, granted in Australia, for its first commercial product, sotrovimab, developed in partnership with GlaxoSmithKline (GSK). This
